Skip to main content

Ex-vivo response to blood products and haemostatic agents after paediatric cardiac surgery.

Hvas AM, Andreasen JB, Christiansen K, Ravn HB

Publication: Blood Coagul Fibrinolysis (2013) • Vol 24 • Page 587-92PMID: 23571685View on PubMed

Purpose

The purpose of this paper was to determine the effects of undergoing cardiac surgery and the ex vivo addition of haemostatic agents on hematology and coagulation parameters in pediatric blood specimens.

Conclusion

Specimens that were collected after patients had undergone cardiac surgery had significantly decreased platelet counts, fibrinogen concentrations, prothrombin time (PT), clot propagation maximum velocity (MaxVel), and maximum clot firmness (MCF), and significantly increased thrombin time (TT), D-dimer concentration, clot initiation time, and termination (t), MaxVel compared to those specimens collected before surgery. Activated partial thromboplastin time (aPTT) and factor XIII were not significantly affected by undergoing cardiac surgery. Of the 6 haemostatic agents tested for the ability to reverse coagulation profiles to preoperative values by ex vivo addition, pooled platelets showed the largest effect.

Studies (1)

Purpose

The purpose of this study was to determine the effects of undergoing cardiac surgery and the ex vivo addition of haemostatic agents on hematology and coagulation parameters in 54 pediatric blood specimens. Specimens were obtained before heparinization and after the end of cardiopulmonary bypass and Protaminsulfate administration into EDTA tubes for platelet counts and into citrate tubes for the measurement of aPTT, PT, TT, fibrinogen, D-dimer, and thromboelastometric whole blood coagulation profiles.

Summary of Findings

Specimens that were collected after patients had undergone cardiac surgery had significantly decreased platelet counts (p<0.0001), fibrinogen concentrations (p=0.002), PT (p<0.0001), clot propagation MaxVel (p<0.001), and MCF (p<0.001), and significantly increased TT (p<0.0001), D-dimer concentration (p<0.0001), clot initiation time (p=0.008), and t, MaxVel (p=0.004) compared to those specimens collected before surgery. aPTT and factor XIII were not significantly affected by undergoing cardiac surgery. Of the 6 haemostatic agents tested for the ability to reverse coagulation profiles to preoperative values by ex vivo addition, pooled platelets showed the largest effect with recombinant factor VIIa also altering clot initiation, propagation, termination, and MCF. Tranexamic acid and factor XIII had the least effects on coagulation profiles.
  • Biospecimens

    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Other diagnoses
    Cardiovascular Disease
  • Platforms

    Cell count/volumeHematology/ auto analyzer
    GlycoproteinHematology/ auto analyzer
    MorphologyHematology/ auto analyzer
    PeptideHematology/ auto analyzer
    ProteinHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Atrial septal defect
    Complete atrioventricular canal
    Congenital heart defect
    Hypoplastic left heart syndrome
    Other reasons for elective cardiac surgery
    Pulmonary atresia
    Tetralogy of Fallot
    Transposition of the great arteries
    Ventricular septal defect
    Biospecimen AcquisitionTime of biospecimen collection
    Postoperative
    Preoperative
    Biospecimen Aliquots and ComponentsBiospecimen components
    Factor XIII
    Fibrinogen concentrate
    Fresh frozen plasma
    Pooled platelets
    Recombinant factor VIIa
    Tranexamic acid